Core Insights - Shenzhen Yirui Biotechnology Co., Ltd. reported a significant improvement in its financial performance for the third quarter of 2025, with a notable increase in revenue and a return to profitability in net profit after deducting non-recurring items [1] Financial Performance - For the first three quarters of 2025, the company achieved operating revenue of 186 million yuan, representing a year-on-year growth of 17.45% [1] - The net profit attributable to the parent company reached 18.02 million yuan, with a remarkable third-quarter revenue of 76.35 million yuan, up 40.34% year-on-year [1] - The company turned around its net profit after deducting non-recurring items, reaching 3.73 million yuan for the first three quarters, and 5.79 million yuan for the third quarter alone [1] Research and Development - The company maintained strong investment in research and development, with R&D expenses amounting to 30.82 million yuan in the first three quarters of 2025, an increase of 7.00% year-on-year [1] - R&D investment accounted for 16.60% of the company's revenue, indicating a commitment to innovation and technology advancement [1] Strategic Initiatives - The company is actively advancing the construction of an automated intelligent food safety testing platform and is strategically positioning itself in the chemiluminescence technology sector [1] - By leveraging a dual approach of "automated intelligence + technology platform," the company aims to reinforce its technological advantages and drive long-term growth [1]